NEW YORK – The methylation profiles of circulating tumor DNA may help diagnose colorectal cancer as well as predict patient prognosis, findings that may form the basis of a new cancer test.
Early detection of colorectal cancer helps improve patients' survival, but colonoscopy-based screening is invasive, time-consuming, and expensive, all of which may adversely influence patient compliance.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology